We found evidence for a causal effect of higher genetically predicted liver fat on increased liver cancer risk, higher genetically predicted pancreas fat on increased endometrioid ovarian cancer risk, and higher genetically predicted ASAT on decreased luminal B/HER2-negative-like and triple-negative or basal-like breast cancer risk. The gene discussed is ERBB2; the disease is ovarian endometrioid adenocarcinoma.